カテゴリー： 世界, 医療/バイオ, MarketsandMarkets

遠隔患者モニタリング（RPM）のグローバル市場予測（～2028）：ソフトウェア、サービス、機器、循環器、神経、血圧モニター、新生児、体重、体温、神経

【英語タイトル】Remote Patient Monitoring Market / RPM Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Home care, Patients, Payers) & Region - Global Forecast to 2028

MarketsandMarketsが出版した調査資料（HIT7776-23）・商品コード：HIT7776-23
・発行会社（調査会社）：MarketsandMarkets
・発行日：2023年11月7日
・ページ数：306
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

“世界の遠隔患者モニタリング（RPM）市場は、2023年の140億米ドルから2028年には417億米ドルに達し、2023年から2028年の年平均成長率は20.1％と予測”高齢者人口の増加、医療アクセスの拡大ニーズの高まり、医療資源の負担を軽減するRPMの能力、慢性疾患の有病率の上昇が、遠隔患者モニタリング（RPM）市場の成長を促進する主な要因です。しかし、ソーシャルメディアの非公式な利用が予測期間中の市場成長を抑制する可能性があります。

“ソフトウェアとサービスセグメントが予測期間中に市場で最大のシェアを占めると推定”
製品に基づいて、遠隔患者モニタリング（RPM）は、ソフトウェア＆サービスとデバイスにセグメント化されます。予測期間中、最大のシェアを占めると推定されるのはソフトウェア＆サービス分野です。このセグメントの最大シェアは、主に利便性、遠隔患者モニタリング（RPM）の高い有用性、IoT（モノのインターネット）で経験した技術革新によるものです。

“心臓モニタリング機器セグメントは2022年に市場で最大のシェアを占めると推定”
タイプ別では、デバイス市場はさらに神経モニタリングデバイス、マルチパラメータモニタリングデバイス 、心臓モニタリングデバイス、呼吸モニタリングデバイス、血糖モニタリングデバイス、胎児＆新生児モニタリングデバイス、およびその他のモニタリングデバイスにセグメント化されます。2022年、遠隔患者モニタリング（RPM）市場で最大のシェアを占めたのは心臓モニタリング機器。高血圧と心血管疾患の有病率の増加が、この市場の成長を促進すると推定されています。

“2022年の遠隔患者モニタリング（RPM）市場の用途別シェアは糖尿病分野が最大”
アプリケーション別に見ると、世界の遠隔患者モニタリング（RPM）市場は、腫瘍学、心血管疾患、糖尿病、睡眠障害、体重管理、フィットネスモニタリングに分類されます。2022年の世界市場で最大のシェアを占めるのは糖尿病分野でした。これは、糖尿病の有病率と慢性的な性質、継続的なモニタリング要件、および技術の進歩によるものです。
2022年のエンドユーザー別遠隔患者モニタリング（RPM）市場で最大のシェアを占める医療機関セグメント
世界の遠隔患者モニタリング（RPM）市場は、プロバイダー、支払者、患者、その他の4つの主要エンドユーザーセグメントに分類されます。2022年の世界市場で最大のシェアを占めるのはプロバイダーセグメントでした。これは、RPMモニタリング機器が改良され、より多くの慢性疾患患者や高齢患者がリモートモニタリングを利用し、プロバイダーがより多くのRPMサービスを提供しているためです。

“アジア太平洋は予測期間中に最も高いCAGRを記録すると予測”
アジア太平洋の市場は、予測期間中に最も高いCAGRを記録すると予測されています。これは、インドや中国などの新興アジア太平洋諸国が、高齢者人口の増加、医療制度の改善、急速な経済発展、生活水準の向上により、遠隔患者モニタリング（RPM）企業にとって魅力的な市場となっているためです。

供給側の一次インタビューの内訳は以下の通りです（企業タイプ別、呼称別、地域別 ）：
- 企業タイプ別：ティア1（35％）、ティア2（45％）、ティア3（20％）
- 役職別：Cレベル（35％）、ディレクターレベル（25％）、その他（40％）
- 地域別：北米 (25％)、ヨーロッパ (15％)、アジア太平洋 (45％)、中南米 (10％)、中東アフリカ (5％)

この市場に参入している主要企業には、Oracle (US), Siemens Healthineers AG (Germany), Omron Healthcare (Japan), Boston Scientific Corporation (US), Clear Arch, Inc (US), TytoCare Ltd. (US), Teledoc Health Inc. (US), Vivify Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), Brook Inc. (US), Blue Spark Technology (US), Welch Allyn (US), Health Beats (Singapore),Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Alten Calsoft Labs (France), Bio-Beat (Israel), VitalConnect (US), VivaLNK Inc. (US), Bardy Diagnsotics, Inc. (US), Biotronik SE & Co. KG (Germany), Alive Cor, Inc. (US), and iRhythm Technologies (US)などが含まれます。

調査範囲：
- 遠隔患者モニタリング（RPM）市場を製品、用途、エンドユーザー、地域別に調査しています。
- 市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- 遠隔患者モニタリング（RPM）市場の成長動向、将来性、市場全体への貢献に関して、ミクロ市場を調査しています。
- 主要5地域に関して、市場セグメントの収益を予測しています。

レポート購入の主な利点：
本レポートは、市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、関係者が医療用外骨格市場の脈拍を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
- 主な促進要因（老年人口および医療サービスが行き届いていない（特に農村部）人口の増加；慢性疾患の有病率の増加；パンデミックによる医師およびケア要員不足の現状に起因するテレヘルスおよび遠隔医療の利点； 遠隔医療とRPMへの投資の増加、電気通信における技術進歩の高まり）、阻害要因（不十分なAI労働力、医療ソフトウェアに関する曖昧な規制ガイドライン）、機会（遠隔患者モニタリング（RPM）市場におけるAIの役割と影響、感染症や伝染病対策におけるRPMの高い有用性）、課題（行動上の障壁、医療費負担、認識不足）の分析を提供しています。
- 市場への浸透： 遠隔患者モニタリング（RPM）市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報を掲載しています。本レポートでは、この市場をタイプ別、用途別、エンドユーザー別に分析しています。
- サービスの強化/革新： 遠隔患者モニタリング（RPM）市場の今後の動向に関する詳細な洞察を記載しています。
- 市場開発： 有利な新興市場のタイプ、アプリケーション、エンドユーザーに関する包括的な情報を掲載しています。
- 市場の多様化： 遠隔患者モニタリング（RPM）市場における新しいデバイスやソフトウェア、成長地域、最近の開発、投資に関する詳細情報を掲載しています。
- 競合評価： 遠隔患者モニタリング（RPM）市場における主要企業の市場シェア、成長戦略、製品提供、企業評価象限、能力を詳細に評価します。

1.　イントロダクション
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の遠隔患者モニタリング（RPM）市場規模：種類別
7.　世界の遠隔患者モニタリング（RPM）市場規模：用途別
8.　世界の遠隔患者モニタリング（RPM）市場規模：エンドユーザー別
9.　世界の遠隔患者モニタリング（RPM）市場規模：地域別
10.　競争環境
11.　企業情報
12.　付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.2.1 INCLUSIONS AND EXCLUSIONS 40
1.3 MARKET SEGMENTATION 41
1.3.1 REGIONAL SEGMENTATION 41
1.3.2 YEARS CONSIDERED 42
1.3.3 CURRENCY CONSIDERED 42
1.4 STAKEHOLDERS 42
1.5 LIMITATIONS 43
1.5.1 SCOPE-RELATED LIMITATIONS 43
1.5.2 METHODOLOGY-RELATED LIMITATIONS 43
1.6 SUMMARY OF CHANGES 43
1.7 RECESSION IMPACT 44
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
FIGURE 1 RESEARCH DESIGN 45
2.1.1 SECONDARY DATA 46
2.1.1.1 Key data from secondary sources 46
2.1.2 PRIMARY DATA 47
FIGURE 2 PRIMARY SOURCES 47
2.1.2.1 Key data from primary sources 48
FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS 48
2.1.2.2 Breakdown of primary sources 49
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.2 MARKET SIZE ESTIMATION 49
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 50
FIGURE 6 REMOTE PATIENT MONITORING MARKET: ESTIMATION OF MARKET SIZE THROUGH ADOPTION-BASED APPROACH 51
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 53
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
FIGURE 9 TOP-DOWN APPROACH 54
TABLE 1 IMPACT ANALYSIS 55
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 56
FIGURE 10 DATA TRIANGULATION METHODOLOGY 56
2.4 STUDY ASSUMPTIONS 57
2.5 RISK ASSESSMENT 57
TABLE 2 RISK ASSESSMENT ANALYSIS 57
2.6 RECESSION IMPACT ANALYSIS 58
3 EXECUTIVE SUMMARY 59
FIGURE 11 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 12 REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60
FIGURE 13 REMOTE PATIENT MONITORING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 60
FIGURE 14 GEOGRAPHIC SNAPSHOT OF REMOTE PATIENT MONITORING MARKET 61
4 PREMIUM INSIGHTS 62
4.1 REMOTE PATIENT MONITORING MARKET OVERVIEW 62
FIGURE 15 RISING POPULATION AND GROWING FOCUS ON EXPANDING HEALTHCARE TO DRIVE MARKET DURING FORECAST PERIOD 62
4.2 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE AND COUNTRY (2022) 63
FIGURE 16 SOFTWARE & SERVICES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 63
4.3 REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC MIX 64
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 64
4.4 REMOTE PATIENT MONITORING MARKET: DEVELOPED VS. EMERGING MARKETS 64
FIGURE 18 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
FIGURE 19 REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
5.2 DRIVERS 66
5.2.1 GROWTH IN POPULATION AND SUBSEQUENT NEED TO EXPAND HEALTHCARE ACCESS 66
5.2.2 COST BENEFITS OF TELEHEALTH 66
TABLE 3 CHRONIC DISEASES AND COST BURDEN IN US: POTENTIAL SAVINGS 67
5.2.3 ABILITY TO REDUCE BURDEN ON MEDICAL RESOURCES 67
5.2.4 ADVANCEMENTS IN TELECOMMUNICATION 67
5.2.5 RISING INVESTMENTS IN TELEHEALTH SOLUTIONS 68
5.3 RESTRAINTS 68
5.3.1 VARIABLE REGULATORY STANDARDS ACROSS REGIONAL MARKETS 68
TABLE 4 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH 69
5.3.2 HEALTHCARE FRAUD 70
5.3.3 INFORMAL USAGE OF SOCIAL MEDIA FOR HEALTHCARE PRACTICES 70
5.4 OPPORTUNITIES 70
5.4.1 IMPACT OF AI ON REMOTE PATIENT MONITORING 70
5.4.2 HIGH UTILIZATION IN INFECTIOUS DISEASE MONITORING 71
5.5 CHALLENGES 72
5.5.1 BEHAVIORAL BARRIERS AND HEALTHCARE AFFORDABILITY 72
5.5.2 DATA ACCESSIBILITY ISSUES 72
5.6 INDUSTRY TRENDS 72
5.6.1 GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE 72
5.6.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY 73
5.7 TARIFF AND REGULATORY ANALYSIS 74
5.7.1 TARIFF FOR REMOTE PATIENT MONITORING DEVICES 74
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 5 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.7.3 NORTH AMERICA 75
5.7.3.1 US 75
TABLE 6 US: CLASSIFICATION OF MEDICAL EQUIPMENT 75
TABLE 7 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 75
5.7.3.2 Canada 75
TABLE 8 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 75
5.7.3.3 Europe 76
TABLE 9 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 76
5.7.3.4 Asia Pacific 76
5.7.3.4.1 Japan 76
TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 77
5.7.3.4.2 China 77
TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 78
5.7.3.4.3 India 78
5.8 ECOSYSTEM ANALYSIS 78
FIGURE 20 REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS 79
5.9 VALUE CHAIN ANALYSIS 79
FIGURE 21 REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS 80
5.10 TECHNOLOGY ANALYSIS 80
5.10.1 REMOTE PATIENT MONITORING MARKET: DIGITAL TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES 80
5.11 PATENT ANALYSIS 81
5.11.1 PATENT PUBLICATION TRENDS 81
FIGURE 22 PATENT PUBLICATION TRENDS: JANUARY 2011−SEPTEMBER 2023 82
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR REMOTE PATIENT MONITORING PATENTS (2011−2023) 82
TABLE 12 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS 82
5.11.3 REMOTE PATIENT MONITORING MARKET: TOP APPLICANTS 83
FIGURE 23 TOP APPLICANTS FOR REMOTE PATIENT MONITORING PATENTS (2011–2023) 83
5.11.4 REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS 83
5.12 TRADE ANALYSIS 84
5.12.1 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES 85
FIGURE 24 IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND) 85
FIGURE 25 EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND) 85
5.13 CASE STUDY ANALYSIS 86
TABLE 13 CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA INTO MEDTRONIC CARE MANAGEMENT SERVICES (MCMS) RPM PLATFORM 86
TABLE 14 CASE STUDY 2: MOTION-SENSOR TECHNOLOGY FOR EARLY DETECTION OF CVD 86
5.14 PORTER’S FIVE FORCES ANALYSIS 87
TABLE 15 REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 87
5.14.1 THREAT OF NEW ENTRANTS 87
5.14.2 THREAT OF SUBSTITUTES 88
5.14.3 BARGAINING POWER OF MANUFACTURERS 88
5.14.4 BARGAINING POWER OF BUYERS 88
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 88
5.15 KEY CONFERENCES AND EVENTS 89
5.15.1 LIST OF KEY CONFERENCES AND EVENTS (2023−2024) 89
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 90
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING 90
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY TYPE 91
5.16.2 BUYING CRITERIA 91
FIGURE 26 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY TYPE 91
TABLE 18 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING 91
5.17 PRICING ANALYSIS 92
TABLE 19 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYERS (2022) 92
TABLE 20 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY DEVICES (2022) 93
TABLE 21 INDICATIVE PRICING ANALYSIS OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2021 (USD) 93
5.18 REMOTE PATIENT MONITORING MARKET: UNMET NEEDS ANALYSIS 94
TABLE 22 UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET 94
5.18.1 REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS 94
TABLE 23 END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET 95
5.19 REIMBURSEMENT SCENARIO 96
TABLE 24 CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET 96
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 97
5.20.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET 97
6 REMOTE PATIENT MONITORING MARKET, BY TYPE 98
6.1 INTRODUCTION 99
TABLE 25 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
6.2 SOFTWARE & SERVICES 99
6.2.1 AVAILABILITY OF REIMBURSEMENTS FOR RPM SERVICES TO PROPEL MARKET 99
TABLE 26 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY REGION, 2021–2028 (USD MILLION) 100
TABLE 27 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 28 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 29 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 30 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.3 DEVICES 102
TABLE 31 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 32 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 33 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 34 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 35 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 36 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.3.1 CARDIAC MONITORING DEVICES 106
TABLE 37 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 38 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 39 EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 40 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 41 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 42 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2021–2028 (USD MILLION) 109
6.3.1.1 BLOOD PRESSURE MONITORING DEVICES 109
6.3.1.1.1 Growing preference for wearable smartphone-connected devices to boost demand 109
TABLE 43 REMOTE PATIENT MONITORING MARKET FOR BLOOD PRESSURE MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 110
6.3.2 NEUROLOGICAL MONITORING DEVICES 110
6.3.2.1 Rising cases of epilepsy and Alzheimer’s to support market growth 110
TABLE 44 REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 45 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 46 EUROPE: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 47 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 48 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.3.3 RESPIRATORY MONITORING DEVICES 113
6.3.3.1 Growing adoption of pulse oximeters to drive market 113
TABLE 49 REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 50 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 51 EUROPE: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 52 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 53 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 116
6.3.4 MULTIPARAMETER MONITORING DEVICES 116
6.3.4.1 Ability to measure multi-physiological and biochemical ranges to boost demand 116
TABLE 54 REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 55 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 56 EUROPE: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 57 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 58 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.3.5 BLOOD GLUCOSE MONITORING DEVICES 119
6.3.5.1 High incidence of diabetes to drive market 119
TABLE 59 REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 60 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 61 EUROPE: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 62 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 63 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 122
6.3.6 FETAL & NEONATAL MONITORING DEVICES 122
6.3.6.1 Rising number of preterm births to propel market for RPM devices 122
TABLE 64 REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 65 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 66 EUROPE: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 67 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 68 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.3.7 WEIGHT MONITORING DEVICES 125
6.3.7.1 Rising obesity levels to fuel uptake 125
TABLE 69 REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 70 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 71 EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 72 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 73 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.3.8 OTHER MONITORING DEVICES 128
TABLE 74 REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 75 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 76 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 77 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 78 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021–2028 (USD MILLION) 131
7 REMOTE PATIENT MONITORING MARKET, BY APPLICATION 132
7.1 INTRODUCTION 133
TABLE 79 REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 133
7.2 ONCOLOGY 133
7.2.1 RISING INCIDENCE OF CANCER TO PROPEL MARKET 133
TABLE 80 REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 81 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 82 EUROPE: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 83 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 84 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.3 CARDIOVASCULAR DISEASES 136
7.3.1 HIGH INCIDENCE OF CVD TO SUPPORT MARKET GROWTH 136
TABLE 85 REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 86 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 87 EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 88 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 89 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 138
7.4 DIABETES 138
7.4.1 TECHNOLOGICAL ADVANCEMENTS IN WEARABLE MONITORS TO BOOST DEMAND 138
TABLE 90 REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 91 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 92 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 93 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 94 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION) 141
7.5 SLEEP DISORDERS 141
7.5.1 WIDE UTILIZATION IN SLEEP APNEA MANAGEMENT TO PROPEL MARKET 141
TABLE 95 REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 96 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 97 EUROPE REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 98 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 99 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021–2028 (USD MILLION) 144
7.6 WEIGHT MANAGEMENT AND FITNESS MONITORING 144
7.6.1 CHRONIC DISEASE MANAGEMENT TO SUPPORT MARKET GROWTH 144
TABLE 100 REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 101 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 102 EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 103 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT & FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 104 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021–2028 (USD MILLION) 147
7.7 OTHER APPLICATIONS 147
TABLE 105 REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 106 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 107 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 108 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 109 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 150
8 REMOTE PATIENT MONITORING MARKET, BY END USER 151
8.1 INTRODUCTION 152
TABLE 110 REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 152
8.2 PROVIDERS 152
TABLE 111 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 112 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 113 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 114 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 115 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 116 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 156
8.2.1 HOSPITALS AND CLINICS 156
8.2.1.1 High incidence of infectious diseases to boost demand 156
TABLE 117 REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021–2028 (USD MILLION) 157
TABLE 118 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 119 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 120 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 121 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 159
8.2.2 HOME CARE SETTINGS AND LONG-TERM CARE CENTERS 159
8.2.2.1 Advancements in wearable health technology to support market growth 159
TABLE 122 REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 123 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 124 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 125 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 126 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 162
8.2.3 AMBULATORY CARE CENTERS 162
8.2.3.1 Gradual shift to outpatient settings to propel market 162
TABLE 127 REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 128 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 129 EUROPE: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 130 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 131 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 165
8.2.4 OTHER PROVIDERS 165
TABLE 132 REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 133 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 134 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 135 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 136 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 167
8.3 PAYERS 167
8.3.1 INCREASING REIMBURSEMENTS FOR RPM SOLUTIONS TO PROPEL MARKET 167
TABLE 137 REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION) 168
TABLE 138 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 139 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 140 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 141 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 170
8.4 PATIENTS 170
8.4.1 COST-BENEFITS AND CONVENIENCE OFFERED BY RPM TO SUPPORT MARKET 170
TABLE 142 REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION) 171
TABLE 143 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 144 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 145 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 146 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION) 173
8.5 OTHER END USERS 173
TABLE 147 REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 174
TABLE 148 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 149 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 150 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 151 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 176
9 REMOTE PATIENT MONITORING MARKET, BY REGION 177
9.1 INTRODUCTION 178
TABLE 152 REMOTE PATIENT MONITORING MARKET, BY REGION, 2021–2028 (USD MILLION) 178
9.2 NORTH AMERICA 178
FIGURE 27 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT 179
9.2.1 NORTH AMERICA: RECESSION IMPACT 179
TABLE 153 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 154 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 155 NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 156 NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 157 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 182
TABLE 158 NORTH AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 183
9.2.2 US 183
9.2.2.1 High healthcare expenditure to boost demand for RPM services 183
TABLE 159 US: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 160 US: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 161 US: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 162 US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 186
TABLE 163 US: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 186
9.2.3 CANADA 187
9.2.3.1 Rising incidence of CVD to support market growth 187
TABLE 164 CANADA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 165 CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 166 CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 167 CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 189
TABLE 168 CANADA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 189
9.3 EUROPE 190
9.3.1 EUROPE: RECESSION IMPACT 190
TABLE 169 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 170 EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 171 EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 172 EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 173 EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 193
TABLE 174 EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 193
9.3.2 GERMANY 194
9.3.2.1 Rapid digitization of healthcare systems to drive market growth 194
TABLE 175 GERMANY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 176 GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 177 GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 196
TABLE 178 GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 196
TABLE 179 GERMANY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 197
9.3.3 UK 197
9.3.3.1 Shortage of physicians to boost demand for telehealth solutions 197
TABLE 180 UK: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 181 UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 182 UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 199
TABLE 183 UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 199
TABLE 184 UK: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY END USER, 2021–2028 (USD MILLION) 200
9.3.4 FRANCE 200
9.3.4.1 Favorable government initiatives for telehealth to support market growth 200
TABLE 185 FRANCE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 186 FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 187 FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 202
TABLE 188 FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 202
TABLE 189 FRANCE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 203
9.3.5 ITALY 203
9.3.5.1 Growing focus on improvements in patient care to drive market 203
TABLE 190 ITALY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 191 ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 192 ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 205
TABLE 193 ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 205
TABLE 194 ITALY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 206
9.3.6 SPAIN 206
9.3.6.1 Rising incidence of chronic diseases to support market growth 206
TABLE 195 SPAIN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 196 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 197 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 198 SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 208
TABLE 199 SPAIN: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 209
9.3.7 REST OF EUROPE 209
TABLE 200 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 201 REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 202 REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 203 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 211
TABLE 204 REST OF EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 212

9.4 ASIA PACIFIC 212
FIGURE 28 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT 213
9.4.1 ASIA PACIFIC: RECESSION IMPACT 213
TABLE 205 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 206 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 207 ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 208 ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 215
TABLE 209 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 216
TABLE 210 ASIA PACIFIC: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 216
9.4.2 CHINA 216
9.4.2.1 High adoption of telemedicine to drive market 216
TABLE 211 CHINA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 212 CHINA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 213 CHINA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 218
TABLE 214 CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 218
TABLE 215 CHINA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 219
9.4.3 JAPAN 219
9.4.3.1 Rising geriatric population and universal healthcare coverage to boost demand 219
TABLE 216 JAPAN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 217 JAPAN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 218 JAPAN: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 221
TABLE 219 JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 221
TABLE 220 JAPAN: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 222
9.4.4 INDIA 222
9.4.4.1 Favorable government policies and high density of population in rural areas to propel market 222
TABLE 221 INDIA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 222 INDIA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 223 INDIA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 224 INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 225
TABLE 225 INDIA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 225
9.4.5 REST OF ASIA PACIFIC 226
TABLE 226 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 227 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 228 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 227
TABLE 229 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 228
TABLE 230 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 228
9.5 LATIN AMERICA 229
9.5.1 LATIN AMERICA: RECESSION IMPACT 229
TABLE 231 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 229
TABLE 232 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 233 LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 234 LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 231
TABLE 235 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 231
TABLE 236 LATIN AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 232
9.5.2 BRAZIL 232
9.5.2.1 Rising adoption of telehealth solutions to support market growth 232
TABLE 237 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 238 BRAZIL: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 239 BRAZIL: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 233
TABLE 240 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 234
TABLE 241 BRAZIL: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 234
9.5.3 MEXICO 235
9.5.3.1 Improvements in healthcare infrastructure to boost demand 235
TABLE 242 MEXICO: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 243 MEXICO: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 244 MEXICO: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 236
TABLE 245 MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 237
TABLE 246 MEXICO: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 237
9.5.4 REST OF LATIN AMERICA 238
TABLE 247 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 248 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 249 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 239
TABLE 250 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 240
TABLE 251 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 240
9.6 MIDDLE EAST & AFRICA 241
9.6.1 GOVERNMENT INITIATIVES FOR INVESTMENTS IN RPM SOLUTIONS TO SUPPORT MARKET GROWTH 241
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 241
TABLE 252 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 253 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 254 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 243
TABLE 255 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021–2028 (USD MILLION) 243
TABLE 256 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021–2028 (USD MILLION) 244
10 COMPETITIVE LANDSCAPE 245
10.1 INTRODUCTION 245
10.2 KEY PLAYER STRATEGIES 245
TABLE 257 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS (JANUARY 2020−OCTOBER 2023) 245
10.3 REVENUE SHARE ANALYSIS 247
FIGURE 29 REVENUE SHARE ANALYSIS OF KEY PLAYERS 247
10.4 MARKET SHARE ANALYSIS 247
FIGURE 30 REMOTE PATIENT MONITORING MARKET: RANKING OF KEY COMPANIES (2022) 248
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 249
10.5.1 STARS 249
10.5.2 EMERGING LEADERS 249
10.5.3 PERVASIVE PLAYERS 249
10.5.4 PARTICIPANTS 249
FIGURE 31 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (2022) 250
10.5.5 COMPANY FOOTPRINT 251
TABLE 258 REMOTE PATIENT MONITORING MARKET: OVERALL COMPANY FOOTPRINT 251
TABLE 259 REMOTE PATIENT MONITORING MARKET: TYPE FOOTPRINT 252
TABLE 260 REMOTE PATIENT MONITORING MARKET: APPLICATION FOOTPRINT 253
TABLE 261 REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT 254
TABLE 262 REMOTE PATIENT MONITORING MARKET: REGIONAL FOOTPRINT 255
10.6 START-UP/SME EVALUATION MATRIX 256
10.6.1 PROGRESSIVE COMPANIES 256
10.6.2 RESPONSIVE COMPANIES 256
10.6.3 DYNAMIC COMPANIES 256
10.6.4 STARTING BLOCKS 256
FIGURE 32 REMOTE PATIENT MONITORING MARKET: START-UP/SME EVALUATION MATRIX (2022) 257
10.6.5 COMPETITIVE BENCHMARKING 257
TABLE 263 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY START-UPS/SMES 257
10.7 COMPETITIVE SCENARIOS AND TRENDS 258
10.7.1 PRODUCT LAUNCHES & APPROVALS 258
TABLE 264 REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–OCTOBER 2023) 258
10.7.2 DEALS 258
TABLE 265 REMOTE PATIENT MONITORING MARKET: KEY DEALS (JANUARY 2020−OCTOBER 2023) 258
11 COMPANY PROFILES 260
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS 260
11.1.1 KONINKLIJKE PHILIPS N.V. 260
TABLE 266 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 260
FIGURE 33 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 261
11.1.2 MEDTRONIC PLC 265
TABLE 267 MEDTRONIC PLC: BUSINESS OVERVIEW 265
FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 266
11.1.3 OMRON HEALTHCARE, INC. 271
TABLE 268 OMRON HEALTHCARE, INC.: BUSINESS OVERVIEW 271
FIGURE 35 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT (2022) 272
11.1.4 BOSTON SCIENTIFIC CORPORATION 276
TABLE 269 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 276
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 277
11.1.5 GE HEALTHCARE 279
TABLE 270 GE HEALTHCARE: BUSINESS OVERVIEW 279
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 280
11.1.6 ABBOTT LABORATORIES 283
TABLE 271 ABBOTT LABORATORIES: BUSINESS OVERVIEW 283
FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 284
11.1.7 ORACLE 286
TABLE 272 ORACLE: BUSINESS OVERVIEW 286
FIGURE 39 ORACLE: COMPANY SNAPSHOT (2022) 287
11.1.8 ALTEN CALSOFT LABS (SUBSIDIARY OF ALTEN GROUP) 289
TABLE 273 ALTEN GROUP: BUSINESS OVERVIEW 289
FIGURE 40 ALTEN GROUP: COMPANY SNAPSHOT (2022) 290
11.1.9 SIEMENS HEALTHINEERS 291
TABLE 274 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 291
FIGURE 41 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 292
11.1.10 CLEARARCH, INC. 293
TABLE 275 CLEARARCH, INC.: BUSINESS OVERVIEW 293
11.1.11 BIOBEAT 295
TABLE 276 BIOBEAT: BUSINESS OVERVIEW 295
11.1.12 VIVALNK, INC. 298
TABLE 277 VIVALNK, INC.: BUSINESS OVERVIEW 298
11.1.13 VITALCONNECT 300
TABLE 278 VITALCONNECT: BUSINESS OVERVIEW 300
11.1.14 VIVIFY HEALTH, INC. 302
TABLE 279 VIVIFY HEALTH, INC.: BUSINESS OVERVIEW 302
11.1.15 BARDY DIAGNOSTICS (SUBSIDIARY OF BAXTER) 303
TABLE 280 BARDY DIAGNOSTICS: BUSINESS OVERVIEW 303
11.1.16 BIOTRONIK SE & CO. KG 304
TABLE 281 BIOTRONIK SE & CO.KG: BUSINESS OVERVIEW 304
11.1.17 BROOK, INC. 305
TABLE 282 BROOK, INC.: BUSINESS OVERVIEW 305
11.1.18 BLUE SPARK TECHNOLOGIES, INC. 306
TABLE 283 BLUE SPARK TECHNOLOGY, INC.: BUSINESS OVERVIEW 306
11.2 OTHER PLAYERS 307
11.2.1 WELCH ALLYN (SUBSIDIARY OF HILL-ROM SERVICES, INC.) 307
11.2.2 HEALTHBEATS PTE LTD. 308
11.2.3 ALIVECOR, INC. 308
11.2.4 TYTOCARE LTD. 309
11.2.5 TELADOC HEALTH, INC. 309
11.2.6 IRHYTHM TECHNOLOGIES, INC. 310
11.2.7 DEXCOM, INC. 310
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX 311
12.1 DISCUSSION GUIDE 311
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 314
12.3 CUSTOMIZATION OPTIONS 316
12.4 RELATED REPORTS 316
12.5 AUTHOR DETAILS 317

★調査レポート[遠隔患者モニタリング（RPM）のグローバル市場予測（～2028）：ソフトウェア、サービス、機器、循環器、神経、血圧モニター、新生児、体重、体温、神経] (コード：HIT7776-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[遠隔患者モニタリング（RPM）のグローバル市場予測（～2028）：ソフトウェア、サービス、機器、循環器、神経、血圧モニター、新生児、体重、体温、神経]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • ソフトウェア定義ネットワーク（SDN）のグローバル市場予測（～2028）：SDNインフラ、ソフトウェア、サービス
  • 世界の遠隔患者モニタリング市場（～2030年）：種類別（モニタリング機器、ソフトウェア＆サービス）、状態別（糖尿病、うっ血性心不全、血圧、慢性閉塞性肺疾患、メンタルヘルス、その他）、エンドユーザー別、地域別
  • 抗体薬物複合体（ADC）のグローバル市場予測（～2028）：Kadcyla、Enhertu、Padcev、Polivy
  • スマートロッカーのグローバル市場予測（～2028）：ハードウェア、ソフトウェア、サービス
  • 保険プラットフォームのグローバル市場予測（～2028）：ソフトウェア、サービス

    • ◆H&Iグローバルリサーチのお客様（例）◆